A Senate committee voted Thursday to advance the nominations of Erica Schwartz and Sean Kaufman to key health leadership roles [1].
The move clears a critical legislative hurdle for the administration's efforts to staff the nation's primary public health and emergency response agencies. These positions are central to managing disease outbreaks and coordinating the federal response to medical emergencies.
Schwartz has been nominated to serve as the director of the Centers for Disease Control and Prevention (CDC) [1]. The agency is responsible for protecting public health and safety through the control and prevention of disease, injury, and disability.
Kaufman was nominated for the role of assistant secretary for preparedness and response (ASPR) [1]. This office leads the U.S. government's medical and public health preparedness activities to ensure the country can respond effectively to pandemics or other large-scale health crises.
Both nominations were backed by the committee on July 30, 2026 [1]. The committee's approval means the nominations will now move to the full Senate for a final confirmation vote [1].
These picks are part of a broader effort by the administration to install leadership in the health sector. The confirmation process allows senators to vet the nominees' qualifications and policy goals before they assume official authority over these agencies [1].
“A Senate committee voted Thursday to advance the nominations of Erica Schwartz and Sean Kaufman”
The committee's approval signals a likely path toward confirmation for both nominees. By filling the leadership vacancies at the CDC and ASPR, the administration can solidify its policy direction for public health surveillance and pandemic readiness, reducing the reliance on acting officials to lead these critical agencies.
